Det skal anvendes til radiomærkning af bærestoffer, f. eks. monoklone antistoffer, peptider eller andre substrater.
The contents of the vial of Yttriga is not to be administered directly to the patient but must be used for the radiolabelling of carrier molecules, such as monoclonal antibodies, peptides or other substrates.